Valanx Biotech Raises €3M in Financing
Congrats to our SOSV portfolio company VALANX Biotech on its €3 million in new funding to advance its lead antibody-drug conjugate (ADC) program. The financing...
Tag : Financing
Ten63 Therapeutics Closes Strategic Financing for AI Drug Discovery
SOSV portfolio company and graduate of the IndieBio progrmam, Ten63 Therapeutics recently announced that it added strategic investment from new investors Chugai Venture Fund and...